Immunological evaluation of the new stable ultrasound contrast agent LK565: a phase one clinical trial

BACKGROUND: Ultrasound contrast agents (UCAs) allow the enhancement of vascular definition, thereby providing more diagnostic information. LK565 is a new second-generation UCA based on synthetic polymers of aspartic acid which is eliminated from the blood stream via phagocytosis. LK565 forms very st...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Cardiovasc Ultrasound
Principais autores:	Funke, B, Maerz, HK, Okorokow, S, Polata, S, Lehmann, I, Sack, U, Wild, P, Geisler, T, Zotz, RJ
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2004
Assuntos:	Research
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC520823/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15357870/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1476-7120-2-16
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!